Moraxella catarrhalis vaccine - Wyeth
Latest Information Update: 03 Oct 2011
At a glance
- Originator Wyeth
- Class Bacterial vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Moraxella infections
Most Recent Events
- 22 Jun 2001 No-Development-Reported for Moraxella infections in USA (Unknown route)
- 17 Jul 1997 Preclinical development for Moraxella infections in USA (Unknown route)
- 17 Jul 1997 New profile